Enzo Biochem (ENZ) Short Interest Ratio & Short Volume → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free ENZ Stock Alerts $1.11 +0.01 (+0.91%) (As of 05/16/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Enzo Biochem Short Interest DataCurrent Short Volume676,700 sharesPrevious Short Volume729,200 sharesChange Vs. Previous Month-7.20%Dollar Volume Sold Short$710,535.00Short Interest Ratio / Days to Cover6.0Last Record DateApril 30, 2024Outstanding Shares51,230,000 sharesFloat Size35,620,000 sharesShort Percent of Float1.90%Today's Trading Volume104,991 sharesAverage Trading Volume99,020 sharesToday's Volume Vs. Average106% Short Selling Enzo Biochem ? Sign up to receive the latest short interest report for Enzo Biochem and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatENZ Short Interest Over TimeENZ Days to Cover Over TimeENZ Percentage of Float Shorted Over Time Ad Crypto 101 Media[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. Enzo Biochem Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024676,700 shares $710,535.00 -7.2%1.9%6 $1.05 4/15/2024729,200 shares $845,872.00 +1.2%2.1%6.9 $1.16 3/31/2024720,600 shares $915,162.00 -1.7%2.0%7.6 $1.27 3/15/2024733,100 shares $901,713.00 +2.5%2.1%7.2 $1.23 2/29/2024715,400 shares $951,482.00 -9.8%2.1%6.3 $1.33 2/15/2024792,900 shares $1.07 million +5.1%2.3%7 $1.35 Get the Latest News and Ratings for ENZ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enzo Biochem and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024754,700 shares $950,922.00 -22.8%2.2%7.6 $1.26 1/15/2024978,000 shares $1.36 million -1.6%2.8%9.1 $1.39 12/31/2023994,000 shares $1.38 million -25.3%2.8%9.1 $1.39 12/15/20231,330,000 shares $1.77 million -14.7%3.8%11.8 $1.33 11/30/20231,560,000 shares $1.98 million -3.1%4.4%13.9 $1.27 11/15/20231,610,000 shares $1.98 million -9.0%4.6%13.1 $1.23 10/31/20231,770,000 shares $2.37 million -1.7%5.1%9.8 $1.34 10/15/20231,800,000 shares $2.57 million +0.6%5.2%6 $1.43 9/30/20231,790,000 shares $2.51 million +7.2%5.2%5.4 $1.40 9/15/20231,670,000 shares $2.17 million +13.6%4.8%5 $1.30 8/31/20231,470,000 shares $2.28 million -3.9%3.9%4.4 $1.55 8/15/20231,530,000 shares $2.42 million +5.5%4.0%4.8 $1.58 7/31/20231,450,000 shares $2.15 million +40.8%3.8%5.2 $1.48 7/15/20231,030,000 shares $1.37 million +20.8%3.1%6.5 $1.33 6/30/2023852,900 shares $1.57 million -10.6%2.6%5.3 $1.84 6/15/2023953,500 shares $1.95 million -12.5%2.9%4.8 $2.04 5/31/20231,090,000 shares $2.40 million -8.4%3.3%1.3 $2.20 5/15/20231,190,000 shares $2.83 million -2.5%3.6%1.4 $2.38 4/30/20231,220,000 shares $3.09 million +8.9%3.7%1.4 $2.53 4/15/20231,120,000 shares $2.84 million +8.7%3.4%1.3 $2.54 3/31/20231,030,000 shares $2.50 million +113.8%3.1%1.3 $2.43 3/15/2023481,800 shares $481,800.00 +49.2%1.3%0.6 $1.00 2/28/2023322,900 shares $364,877.00 -6.0%0.9%4.1 $1.13 2/15/2023343,600 shares $439,808.00 -6.8%0.9%4.6 $1.28 1/31/2023368,700 shares $494,058.00 +6.1%1.0%5 $1.34 1/15/2023347,500 shares $528,200.00 +1.0%0.9%5.1 $1.52 12/30/2022344,100 shares $492,063.00 +9.1%1.0%5.2 $1.43 12/15/2022315,300 shares $365,748.00 -21.2%0.9%5.2 $1.16 11/30/2022400,300 shares $796,597.00 +2.4%1.1%8.5 $1.99 11/15/2022391,000 shares $871,930.00 -3.0%1.1%8.3 $2.23 10/31/2022403,100 shares $862,634.00 +5.9%1.1%8.5 $2.14 10/15/2022380,600 shares $806,872.00 -1.8%1.0%8.4 $2.12 9/30/2022387,400 shares $863,902.00 -14.8%1.0%8 $2.23 9/15/2022454,500 shares $1.03 million +12.1%1.2%7 $2.26[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. ENZ Short Interest - Frequently Asked Questions What is Enzo Biochem's current short interest? Short interest is the volume of Enzo Biochem shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 676,700 shares of ENZ short. 1.90% of Enzo Biochem's shares are currently sold short. Learn More on Enzo Biochem's current short interest. What is a good short interest ratio for Enzo Biochem? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ENZ shares currently have a short interest ratio of 6.0. Learn More on Enzo Biochem's short interest ratio. What is a good short interest percentage for Enzo Biochem? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.90% of Enzo Biochem's floating shares are currently sold short. Is Enzo Biochem's short interest increasing or decreasing? Enzo Biochem saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 676,700 shares, a drop of 7.2% from the previous total of 729,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Enzo Biochem's float size? Enzo Biochem currently has issued a total of 51,230,000 shares. Some of Enzo Biochem's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Enzo Biochem currently has a public float of 35,620,000 shares. How does Enzo Biochem's short interest compare to its competitors? 1.90% of Enzo Biochem's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Enzo Biochem: Personalis, Inc. (3.03%), Exagen Inc. (0.05%), DermTech, Inc. (10.13%), Psychemedics Co. (0.35%), Biodesix, Inc. (0.30%), Checkpoint Therapeutics, Inc. (11.50%), Prenetics Global Limited (1.44%), Inotiv, Inc. (4.91%), EUDA Health Holdings Limited (0.11%), Equillium, Inc. (1.99%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Enzo Biochem stock? Short selling ENZ is an investing strategy that aims to generate trading profit from Enzo Biochem as its price is falling. ENZ shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Enzo Biochem? A short squeeze for Enzo Biochem occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ENZ, which in turn drives the price of the stock up even further. How often is Enzo Biochem's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENZ, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Personalis Short Squeeze Exagen Short Squeeze DermTech Short Squeeze Psychemedics Short Squeeze Biodesix Short Squeeze Checkpoint Therapeutics Short Squeeze Prenetics Global Short Squeeze Inotiv Short Squeeze EUDA Health Short Squeeze Equillium Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:ENZ) was last updated on 5/17/2024 by MarketBeat.com Staff From Our Partners348 million Americans lives to END as we know it?The Oxford ClubCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceGold Set to EXPLODE!Gold Safe ExchangeInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaHow Biden has already won 2024Porter & CompanyA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable Prosperity